8 Results for "

PDAC mice

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "PDAC mice" in MCE Product Catalog:

23
23 Publications Verification
Cat. No.: HY-101194
CAS No.: 14325-05-4
Pureté:  96.2%
Synonyms: Tin-protoporphyrin IX; Sn-Protoporphyrin; SnPPIX
Domaines de recherche:  

Cancer

Tin protoporphyrin IX dichloride (SnPPIX) is a potent Heme oxygenase-1 (HO-1) inhibitor. Tin protoporphyrin IX dichloride sensitizes pancreatic ductal adenocarcinoma (PDAC) tumors to chemotherapy in mice model .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-160818
CAS No.: 1844889-12-8
Target:  

Sirtuin

Domaines de recherche:  

Cancer

MC3138 is a selective SIRT5 activator. MC3138 has antitumor activity on human PDAC cells, with IC50 values of 25.4-236.9 μM. MC3138 combined with Gemcitabine (HY-17026) significantly inhibits tumor growth in mice .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P1676
CAS No.: 1975145-82-4
Synonyms: BK-1361
Target:  

MMP

Domaines de recherche:  

Cancer

cyclo(RLsKDK) (BK-1361) is a specific inhibitor of metalloproteinase ADAM8 with an IC50 value of 182 nM. cyclo(RLsKDK) has potential applications in inflammatory diseases and cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P1676A
Synonyms: BK-1361 TFA
Target:  

MMP

Domaines de recherche:  

Cancer

cyclo(RLsKDK) (TFA) (BK-1361 (TFA)) is a specific inhibitor of metalloproteinase ADAM8 with an IC50 value of 182 nM. cyclo(RLsKDK) (TFA) has potential applications in inflammatory diseases and cancer .
loading...
    loading...
Cat. No.: HY-P99555
CAS No.: 1449294-76-1
Synonyms: OPN-305
Tomaralimab (OPN-305) is a humanized anti-TLR2 IgG4 monoclonal antibody. Tomaralimab inhibits TLR2, MyD88, NLRP3, and reduces pro-inflammatory cytokine (IL-1β, IL-6, IL-8) production. Tomaralimab reduces tau pathology. Tomaralimab improves cognition, atopic dermatitis. Tomaralimab has anticancer effects on pancreatic ductal adenocarcinoma. Tomaralimab is being studied in myelodysplastic syndrome (MDS), atopic dermatitis, pancreatic ductal adenocarcinoma, Alzheimer's disease, and myocardial ischemia/reperfusion injury .
loading...
    loading...
Cat. No.: HY-P11785
CAS No.: 1192649-43-6
Target:  

Claudin

Domaines de recherche:  

Cancer

Cpe30 MT2 is a short peptide that binds tightly junction protein Claudin‑4 (CLDN4) with high affinity, with a Kd value of 1.97 nM. Cpe30 MT2 can be used for the synthesis of PET molecular imaging probes targeting pancreatic cancer .
loading...
    loading...
Cat. No.: HY-182241
CAS No.: 2446965-01-9
JR4-187 is an orally active, copper-dependent anticancer agent. JR4-187 downregulates genes involved in oxidative phosphorylation, MYC targets and E2F targets in cancer cells, while upregulates genes involved in the TNF-α signaling pathway, p53 pathway and KRAS signaling pathway, and downregulates CTR1 protein . JR4-187 induces ROS production, apoptosis, copper-dependent cytotoxicity, and exhibits selective cytotoxicity against KRAS-mutant cancer cells. JR4-187 is well tolerated in mouse models of pancreatic cancer. JR4-187 can be used in research related to cancers such as pancreatic ductal adenocarcinoma, colon cancer and rectal cancer .
loading...
    loading...
Cat. No.: HY-183786
Domaines de recherche:  

Cancer

Anticancer agent 327, a fluorescent Andrographolide (HY-N0191) derivative, is an NF-κB p50 inhibitor. Anticancer agent 327 covalently binds to the p50 subunit of NF-κB. Anticancer agent 327 reduces levels of multiple oncogenic p53 proteins via the autophagy/lysosome pathway. Anticancer agent 327 can be used for the research of pancreatic ductal adenocarcinoma (Ex/Em = 488/515 nm)[1].
loading...
    loading...